How could liposomes change CVD treatment?

Decrease font size Reset font size Increase font size

Published 22 February 2012 | Article by Expert Opinion on Drug Delivery 2012

How could liposomes change CVD treatment?

Abstract

Introduction Over the past several decades, liposomes have been used in a variety of applications, from delivery vehicles to cell membrane models. In terms of pharmaceutical use, they can offer control over the release of active agents encapsulated into their lipid bilayer or aqueous core, while providing protection from degradation in the body.

To read the full article, please register for GetInsideHealth below.

Register for GetInsideHealth

GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.

Please fill in the form below to register.

Already Registered?

Please login using
form at top of page

Fields with an asterisk (*) are mandatory

About you

Title

First Name *

Last Name *

Login information

Email Address *

Password (minimum 7 characters) *

Repeat Password *

Tick the box if you want to receive the GetInsideHealth newsletter and other email updates

To personalise your experience, please specify which specialty areas you are interested in

Cardiology

OBGYN

Oncology

Radiology

Health & Well-Being

If you’re interested in receiving occasional e-mail updates from our sponsor, please click here to allow us to share your e-mail address and basic contact information. Your data will not be used by any third party, and you can unsubscribe at any time.